PD-L1, encoded by the gene CD274, interacts with the corresponding receptor programmed cell death protein 1 (PD-1) on the surface of immune cells, which inhibits the antitumor activity of immune cells and allows cancer cells to escape immune surveillance [104]. The gene discussed is CD274; the disease is cancer.